A phase III trial of Tetramethylpyrazine Nitrone for the Treatment of diabetic kidney disease
Latest Information Update: 23 Jan 2025
Price :
$35 *
At a glance
- Drugs Tetramethylpyrazine nitrone (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 23 Jan 2025 New trial record